{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:17:47Z","timestamp":1769127467807,"version":"3.49.0"},"reference-count":8,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1080\/21645515.2020.1793713","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T15:28:14Z","timestamp":1596209294000},"page":"2219-2221","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Seasonal influenza vaccination during a pandemic"],"prefix":"10.1080","volume":"16","author":[{"given":"Heather","family":"Richmond","sequence":"first","affiliation":[{"name":"Seqirus USA, Inc; Seqirus, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Rees","sequence":"additional","affiliation":[{"name":"Seqirus USA, Inc; Seqirus, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"McHale","sequence":"additional","affiliation":[{"name":"Seqirus USA, Inc; Seqirus, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Rak","sequence":"additional","affiliation":[{"name":"Seqirus USA, Inc; Seqirus, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Anderson","sequence":"additional","affiliation":[{"name":"Seqirus USA, Inc; Seqirus, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"cit0001","unstructured":"Stepping up flu vaccine supply - Seqirus to supply additional two million flu vaccines to Australia. 19 April 2020. https:\/\/www.seqirus.com.au\/news\/seqirus-to-supply-additional-two-million-flu-vaccines-to-australia (Accessed 8 July 2020)."},{"key":"cit0002","unstructured":"What If Flu and COVID-19 Overlap? Australia Is Trying to Avoid That Scenario. Healthline. 11 May 2020.https:\/\/www.healthline.com\/health-news\/australia-dealing-with-possible-flu-covid-combination (Accessed 8 July 2020)."},{"key":"cit0003","unstructured":"Researchers report 21% COVID-19 co-infection rate. Center for Infectious Disease and Policy (CIDRAP). 16 April 2020. https:\/\/www.cidrap.umn.edu\/news-perspective\/2020\/04\/researchers-report-21-covid-19-co-infection-rate (Accessed 8 July 2020)."},{"key":"cit0004","unstructured":"European Centre for Disease Prevention and Control (ECDC): Factsheet about seasonal influenza.https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/facts\/factsheet (Accessed 8 July 2020)."},{"key":"cit0005","unstructured":"Centers for Disease Control and Prevention (CDC): Disease Burden of Influenza. Estimated Range of Annual Burden of Flu in the U.S. since 2010. https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html (Accessed 8 July 2020)."},{"key":"cit0006","unstructured":"Higher flu vaccination rates could help expose new viruses like Covid-19 earlier, expert says. The Guardian. 10 April 2020. https:\/\/www.theguardian.com\/world\/2020\/apr\/10\/higher-flu-vaccination-rates-could-help-expose-new-viruses-like-covid-19-earlier-expert-says (Accessed 8 July 2020)."},{"key":"cit0007","unstructured":"Flu shot makers gear up\u2014and get creative\u2014for a critical vaccination season. FiercePharma. 9 June 2020. https:\/\/www.fiercepharma.com\/vaccines\/flu-vaccines-take-even-more-importance-amid-covid-19-but-challenges-await-experts (Accessed 8 July 2020)."},{"key":"cit0008","unstructured":"World Health Organization. Regional Office for Europe. Influenza vaccination coverage and effectiveness. http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/vaccination\/influenza-vaccination-coverage-and-effectiveness (Accessed 8 July 2020)."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1793713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T15:57:15Z","timestamp":1687795035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1793713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1080\/21645515.2020.1793713"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1793713","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}